首页> 外文期刊>Infection and immunity >Quantitative measurements of cholera enterotoxin in cultures of toxinogenic wild-type and nontoxinogenic mutant strains of Vibrio cholerae by using a sensitive and specific reversed passive hemagglutination assay for cholera enerotoxin.
【24h】

Quantitative measurements of cholera enterotoxin in cultures of toxinogenic wild-type and nontoxinogenic mutant strains of Vibrio cholerae by using a sensitive and specific reversed passive hemagglutination assay for cholera enerotoxin.

机译:霍乱弧菌的毒素致病性野生型和非毒素致病性突变菌株培养物中霍乱肠毒素的定量测定,方法是使用敏感的特异性逆向被动血凝法测定霍乱肠毒素。

获取原文
           

摘要

A sensitive and specific reversed passive hemagglutination (RPHA) assay for cholera enterotoxin has been developed. Equine anti-choleragenoid antibodies purified by immunoadsorption were covalently coupled to formalinized sheep erythrocytes, using bis-diazotized benzidine, and the antitoxin-sensitized erythrocytes were shown to agglutinate specifically in the presence of cholera enterotoxin. In a microtiter RPHA assay system, the smallest quantity of enterotoxin that caused hemagglutination was approximately 20 pg. A sensitive assay for antibodies to enterotoxin was also developed, based on inhibition of RPHA. Using such assays, we demonstrated that several nontoxinogenic (tox-) strains of Vibrio cholerae produced small but detectable yields of enterotoxin, 4 to 16 ng/ml, under conditions where the highly toxinogenic strain 569B Inaba produced approximately 16 microgram of enterotoxin per ml. The enterotoxin produced in small quantities by these tox- strains was found to be identical to the enterotoxin from V. cholerae 569B Inaba iv its immunological and biological activities. Strains of V. cholerae that produce intermediate yields of enterotoxin have been obtained by two techniques: (i) as less toxinogenic mutants derived from highly toxinogenic strains and (ii) as more toxinogenic mutants derived from tox- strains. Thus, the yield of enterotoxin in cultures of V. cholerae grown under standardized conditions is is a genetically controlled trait that can be altered by mutation.
机译:已经开发了一种针对霍乱肠毒素的灵敏且特异性的反向被动血凝(RPHA)检测方法。通过双重氮化联苯胺,将通过免疫吸附纯化的马抗胆碱激素样抗体与福尔马林化的绵羊红细胞共价偶联,并且在霍乱肠毒素存在的情况下,抗毒素致敏的红细胞特异性凝集。在微量滴定RPHA分析系统中,引起血凝的最小肠毒素量约为20 pg。基于对RPHA的抑制作用,还开发了一种针对肠毒素抗体的灵敏检测方法。使用此类测定法,我们证明了在高毒素菌株569B Inaba产生每毫升约16微克肠毒素的条件下,霍乱弧菌的几种非毒素菌株都产生了少量但可检测的肠毒素,产量为4至16 ng / ml。发现这些毒株少量产生的肠毒素与其免疫和生物学活性与霍乱弧菌569B Inaba的肠毒素相同。已经通过两种技术获得了产生肠毒素的中间产量的霍乱弧菌菌株:(i)作为源自高毒素菌株的较少的毒素突变体和(ii)作为源自毒素菌株的较多的毒素突变体。因此,在标准化条件下生长的霍乱弧菌培养物中肠毒素的产量是可以通过突变改变的遗传控制性状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号